“I see Medical Affairs co-leading the pharmaceutical and MedTech industries into a new era of patient-centered evidence generation and communication in a valued-based world,” Kremer says.
https://medicalaffairs.org/wp-content/uploads/2023/11/Charlotte-CMO-featured-2.png321845Travis Hegehttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngTravis Hege2023-11-03 10:23:152023-11-07 11:47:19MAPS Appoints Charlotte Kremer, MD, MBA, as Chief Medical Officer
Kesselring will work with the MAPS Professional Development Committee to assist with the creation of courses supporting 7 Medical Affairs competency certification tracks identified in the MAPS 5-year strategic plan.
https://medicalaffairs.org/wp-content/uploads/2023/10/Gustavo-Kesselring-Announcement.png321845Travis Hegehttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngTravis Hege2023-10-19 14:38:512023-10-19 14:38:52MAPS Appoints Dr. Gustavo Kesselring as Senior Advisor for Professional Development
MAPS announces the election of Dr. Danie du Plessis as Chair of the MAPS Board of Directors. Du Plessis is currently Executive Vice-President (EVP) & Head of Medical Affairs at Kyowa Kirin International and is a senior pharmaceutical executive with 30 years’ experience.
https://medicalaffairs.org/wp-content/uploads/2023/04/Danie-du-Plessis-Board-Chair-Featured.png321845Travis Hegehttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngTravis Hege2023-04-11 11:46:272023-04-11 12:12:58Dr. Danie du Plessis Elected Chair of MAPS Board of Directors
From space biology to patient voice to best practices for onboarding, here are highlights of the APPA/MAPS Joint Medical Affairs Summit in Sydney, Australia.
https://medicalaffairs.org/wp-content/uploads/2022/12/Screenshot-2022-12-15-at-9.10.18-AM-1.png9942182Travis Hegehttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngTravis Hege2022-12-15 09:26:552022-12-15 09:28:14Highlights from the APPA/MAPS Joint Medical Affairs Summit 2022
At the MAPS 2022 Global Annual Meeting in New Orleans, we sat down with Medical Affairs leaders in attendance to discuss a range of issues important to the function. Now as we prepare for the MAPS 2023 Global Annual Meeting in Nashville, March 26-29 (early bird registration open until December 31!), join us in looking back at these important opinions. Have a topic you’d like covered at the 2023 meeting? Email MAPS Communications/Marketing Director, Garth Sundem, with your suggestions!
Rob Kaper discusses his vision for the future of Medical Affairs
Charlotte Kremer, Bjorn Oddens and Danie du Plessis discuss whether Medical Affairs has truly achieved its position as the third strategic pillar in industry
Lobna Salem discusses building a Medical Affairs department from scratch
John Pracyk and Bill Sigmund discuss the differences in the practice of Medical Affairs between pharma and MedTech
Riad Dirani and Omar Dabbous discuss the emerging importance of Health Economics and Outcomes research (HEOR) in Medical Affairs
Tamas Koncz talks about the evolution and future of the Medical Affairs professional
Jose Borlolla and Augusto Grinspan discuss the practice of Medical Affairs and the emergence of the pharma industry in Latin America
Danie du Plessis describes the new competencies Medical Affairs professionals will need to succeed in a changing industry ecosystem
Monica de Abadal describes the value of Medical Affairs to patients and society
Marija Simin Geertsen describes her changing view on the role of Medical Affairs in patient engagement
Kirk Shepard and Nicole-Selenko-Gebauer discuss the challenges of diversity in Medical Affairs, both in patients and within industry positions
Jaime Blais, Deb Braccia and Karen Jursca discuss what is medical excellence and how do you do it in this Medical Affairs table talk.
https://medicalaffairs.org/wp-content/uploads/2022/04/Monica-de-Abadal-Medical-Affairs-Table-Talk-Episode-07-WordPress-Image-1.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngMedical Affairs2022-12-07 14:59:172023-04-12 12:46:23Medical Affairs Leadership Interviews from the MAPS 2022 Global Annual Meeting
The Medical Affairs Professional Society (MAPS) is honored to announce the appointment of Charlotte Kremer, MD, MBA as the organization’s Chief Strategy Officer in a volunteer capacity, next to her volunteer role as Chair of the Board of Directors.
The Medical Affairs Professional Society (MAPS) and the Industry Pharmacists Organization (IPhO) are pleased to announce an important new strategic collaboration to help advance the careers of student pharmacists interested in the pharmaceutical industry, as well as Fellows and early-stage Industry Pharmacist professionals.
MAPS is excited to announce the appointment of Tamas Koncz, MD, MSc, PhD, Chief Medical Officer for the Inflammation and Immunology Business at Pfizer, to the MAPS Board of Directors.
MAPS is honored to announce the appointment of William (Bill) Sigmund, MD, MHS, EVP and Chief Medical Officer at Becton Dickinson, to the MAPS Board of Directors.
https://medicalaffairs.org/wp-content/uploads/2022/04/Bill-Sigmund-Board-Featured.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngMedical Affairs2022-04-04 09:02:192022-04-04 09:02:19William Sigmund, MD, MHS Joins Medical Affairs Professional Society (MAPS) Board of Directors
MAPS speaks with co-leads of the Insights Focus Area Working Group (FAWG) about the current state and future directions for Insights in Medical Affairs.
https://medicalaffairs.org/wp-content/uploads/2021/03/Insights-FAWG-Featured-2.png321845Medical Affairshttps://medicalaffairs.org/wp-content/uploads/2022/11/MAPS-Logo-R-NoTagLine.pngMedical Affairs2021-03-24 13:15:192023-11-13 09:44:56The Current State and Future Directions of Insights-Related Activities Within Medical Affairs
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.